Direct Oral Anticoagulant Monotherapy Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: A Meta-Analysis of Randomized Trials
Open Access
- 1 June 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (6) , e016554
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical TrialCirculation, 2025
- Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage OcclusionJAMA Cardiology, 2024
- Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage OcclusionJACC, 2023
- Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage ClosureCirculation: Cardiovascular Interventions, 2020
- The Hartung‐Knapp modification for random‐effects meta‐analysis: A useful refinement but are there any residual concerns?Statistics in Medicine, 2017